Cough syrups, diabetes medicines, and vitamin combinations are among unapproved fixed-dose drugs detected in government lab ...

CytomX Therapeutics shares yo-yoed this past week, surging on positive early clinical data for its colorectal cancer candidate, then retreating on investor questions about the data. Also, Eli Lilly ...

IgA nephropathy, an immune assault on the kidneys, is often missed. New treatments mean that spotting it sooner might save lives ...

Recurrent severe diarrhea with acute kidney injury after drug reinitiation highlights a rare but serious enteropathy linked ...

CytomX Therapeutics (NASDAQ:CTMX) outlined updated Phase 1 dose expansion results for its EpCAM-targeting Probody ...

Confirmed response rates in expansion cohorts of 32% at 10 mg/kg Q3W dose and 20% at 8.6 mg/kg Q3W - - Estimated progression free survival of 7.1 months at 10 mg/kg and 6.8 months at 8.6 mg/kg - - ...

Vertex will use a priority review voucher to expedite the approval of povetacicept in IgAN.

Une femme enceinte asthmatique doit bénéficier d’une prise en charge thérapeutiCorticosteroids and short-acting beta agonists remain the core therapies for pregnant patients with asthma.

I had breast cancer in my left breast 14 years ago. I was treated with chemotherapy and radiation after a lumpectomy and the removal of 14 lymph ...

For some people, the medications have transformed their relationship with physical activity. By Danielle Friedman Jamie Selzler dreaded exercise for as long as he could remember. Throughout his 20s ...

Varseta-M Phase I CRC data, response rates, safety and registrational trial plans for 2027—read key insights now.

The death of Nemesio Oseguera Cervantes dealt a major blow to the Jalisco New Generation Cartel, but few believe it spells the end for the powerful group. By Maria Abi-Habib Reporting from Mexico City ...